These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 11320369

  • 1. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ.
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [Abstract] [Full Text] [Related]

  • 2. Improvement of cardiac output in patients with severe heart failure by use of ACE-inhibitors combined with the AT1-antagonist eprosartan.
    Gremmler B, Kunert M, Schleiting H, Ulbricht LJ.
    Eur J Heart Fail; 2000 Jun; 2(2):183-7. PubMed ID: 10856732
    [Abstract] [Full Text] [Related]

  • 3. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [Abstract] [Full Text] [Related]

  • 4. Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure.
    Hollenberg NK.
    Curr Hypertens Rep; 2001 Sep; 3 Suppl 1():S25-8. PubMed ID: 11580885
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
    Hedner T.
    J Hypertens Suppl; 1999 Jun; 17(2):S21-5. PubMed ID: 10465063
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors.
    Gremmler B, Kisters K, Kunert M, Schleiting H, Ulbricht LJ.
    Acta Cardiol; 2007 Aug; 62(4):321-8. PubMed ID: 17824291
    [Abstract] [Full Text] [Related]

  • 15. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H, Fukuda N, Soeki T, Sakabe K, Onose Y, Tamura Y.
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [Abstract] [Full Text] [Related]

  • 16. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
    Leu HB, Charng MJ, Ding PY.
    Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
    [Abstract] [Full Text] [Related]

  • 17. Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure.
    Havranek EP, Thomas I, Smith WB, Ponce GA, Bilsker M, Munger MA, Wolf RA.
    J Am Coll Cardiol; 1999 Apr; 33(5):1174-81. PubMed ID: 10193713
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V, Mudra H, Bonzel T, Schmidt W, Schlepper M.
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.